þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware (State or Other Jurisdiction of Incorporation or Organization) |
04-3454702 (I.R.S. Employer Identification No.) |
|
439 S. Union St., 5th Floor, Lawrence, MA (Address of Principal Executive Offices) |
01843 (Zip Code) |
Large accelerated filer o
|
Accelerated filer þ | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
PART II OTHER INFORMATION | ||||||||
Item 6. Exhibits | ||||||||
SIGNATURES | ||||||||
INDEX TO EXHIBITS | ||||||||
EX-10.33 | ||||||||
EX-31.1 | ||||||||
EX-31.2 |
Exhibit | ||
Number | ||
**10.32
|
Employment Agreement, dated April 25, 2011, between Registrant and Michael Miller, Jr. (incorporated by reference to Exhibit 10.32 to the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 4, 2011). | |
*10.33
|
Lease, dated as of June 22, 2011, by and between Registrant and 350 Riverwalk, LLC. | |
**10.34
|
Amendment No. 3 to 2005 Stock Incentive Plan of NxStage Medical, Inc. | |
*31.1
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |
*31.2
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |
**32.1
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. | |
**32.2
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. |
* | Filed herewith. | |
** | Previously filed as an exhibit to the Companys Form 10-Q for the quarterly period ended June 30, 2011 filed with the Securities and Exchange Commission on August 3, 2011. | |
| Confidential treatment requested as to certain portions, which portions are omitted and filed separately with the Securities and Exchange Commission. |
2
NXSTAGE MEDICAL, INC. |
||||
By: | /s/ Robert S. Brown | |||
Robert S. Brown | ||||
Chief Financial Officer
(Duly authorized officer and principal financial and accounting officer) |
||||
3
Exhibit | ||
Number | ||
**10.32
|
Employment Agreement, dated April 25, 2011, between Registrant and Michael Miller, Jr. (incorporated by reference to Exhibit 10.32 to the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 4, 2011). | |
*10.33
|
Lease, dated as of June 22, 2011, by and between Registrant and 350 Riverwalk, LLC. | |
**10.34
|
Amendment No. 3 to 2005 Stock Incentive Plan of NxStage Medical, Inc. | |
*31.1
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |
*31.2
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002. | |
**32.1
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. | |
**32.2
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002. |
* | Filed herewith. | |
** | Previously filed as an exhibit to the Companys Form 10-Q for the quarterly period ended June 30, 2011 filed with the Securities and Exchange Commission on August 3, 2011. | |
| Confidential treatment requested as to certain portions, which portions are omitted and filed separately with the Securities and Exchange Commission. |
4